The current resurgence of psychedelic research relies on data and know-how originally generated by drug user communities, who documented toxicity, dosage, and other practical information during decades when public research was prohibited. As legalization approaches, this community-generated knowledge is being transferred to pharmaceutical companies, patented, and turned into billion-dollar assets. This transfer depends on reframing psychedelics as therapeutic rather than recreational. The phenomenon offers a critical lens for examining the concept of 'user innovation' more broadly.
In October 2009, the UK home secretary requested David Nutt's resignation as chair of the government's advisory council on the misuse of drugs after the publication of his paper arguing that ecstasy and LSD are less dangerous than alcohol. Nutt had previously clashed with the Home Office over an editorial comparing the harms of ecstasy unfavorably to those of horse riding. The incident highlighted tensions between academic publication and scientific advice to government. Nutt now chairs the Independent Scientific Committee on Drugs.